S5013
Underlined text would be added to current law. Struck-through text would be removed.
Skip to main content
Go to top ] is old law to be omitted.
LBD09743-02-5
S. 5013 2
1 (ii) As used in this paragraph "opioid antagonist and device" means a
2 drug approved by the food and drug administration that, when adminis-
3 tered, negates or neutralizes in whole or in part the pharmacological
4 effects of an opioid in the body. "Opioid antagonist" shall be limited
5 to naloxone and other medications approved by the department of health
6 for such purpose.
7 (B) The coverage mandated by this paragraph shall include opioid
8 antagonists prescribed or dispensed via standing order or collaborative
9 practice agreement intended for use on patients other than the insured.
10 (C) Coverage provided under this paragraph may be subject to annual
11 deductibles and co-insurance as deemed appropriate by the superintendent
12 and that are consistent with those imposed on other benefits within a
13 given policy.
14 § 3. Section 4303 of the insurance law is amended by adding a new
15 subsection (ww) to read as follows:
16 (ww) (1) (A) Every policy which provides coverage for prescription
17 drugs shall include coverage for at least one opioid antagonist and
18 device. Prior authorization may be required for non-generic forms of
19 opioid antagonists and devices.
20 (B) As used in this subsection "opioid antagonist and device" means a
21 drug approved by the food and drug administration that, when adminis-
22 tered, negates or neutralizes in whole or in part the pharmacological
23 effects of an opioid in the body. "Opioid antagonist" shall be limited
24 to naloxone and other medications approved by the department of health
25 for such purpose.
26 (2) Coverage provided under this subsection may be subject to annual
27 deductibles and co-insurance as deemed appropriate by the superintendent
28 and that are consistent with those imposed on other benefits within a
29 given policy.
30 § 4. This act shall take effect on the thirtieth day after it shall
31 have become a law.
Go to top
<link href="/styles/noscript_styles.css" rel="stylesheet"/>
Sitemap
Request Information
Directions and Maps
New York State Assembly
Speaker Carl E. Heastie
- Assembly Members
- Legislative Info
- Public Hearings
- Speaker's Press
- Assembly Reports
- Committees & More
- Bill Search Home
- Laws
- Legislative Calendar
- Public Hearing Schedule
- Assembly Calendars
- Assembly Committee Agenda
- Summary
- Actions
- Committee Votes
- Floor Votes
- Memo
- Text
- LFIN
- Chamber Video/Transcript
S05013 Summary:
| BILL NO | S05013 |
| SAME AS | No Same As |
| SPONSOR | HARCKHAM |
| COSPNSR | |
| MLTSPNSR | |
| Amd ??3216, 3221 & 4303, Ins L | |
| Requires health insurers to provide coverage for opioid antagonists and devices. |
S05013 Text:
STATE OF NEW YORK ________________________________________________________________________ 5013 2025-2026 Regular Sessions IN SENATE February 18, 2025 ___________ Introduced by Sen. HARCKHAM -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance AN ACT to amend the insurance law, in relation to requiring health insurers to provide coverage for opioid antagonists and devices The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Subsection (i) of section 3216 of the insurance law is 2 amended by adding a new paragraph 41 to read as follows: 3 (41) (A) (i) Every policy which provides coverage for prescription 4 drugs shall include coverage for at least one opioid antagonist and 5 device. Prior authorization may be required for non-generic forms of 6 opioid antagonists and devices. 7 (ii) As used in this paragraph "opioid antagonist and device" means a 8 drug approved by the food and drug administration that, when adminis- 9 tered, negates or neutralizes in whole or in part the pharmacological 10 effects of an opioid in the body. "Opioid antagonist" shall be limited 11 to naloxone and other medications approved by the department of health 12 for such purpose. 13 (B) The coverage mandated by this paragraph shall include opioid 14 antagonists prescribed or dispensed via standing order or collaborative 15 practice agreement intended for use on patients other than the insured. 16 (C) Coverage provided under this paragraph may be subject to annual 17 deductibles and co-insurance as deemed appropriate by the superintendent 18 and that are consistent with those imposed on other benefits within a 19 given policy. 20 § 2. Subsection (l) of section 3221 of the insurance law is amended by 21 adding a new paragraph 7-c to read as follows: 22 (7-c) (A) (i) Every policy which provides coverage for prescription 23 drugs shall include coverage for at least one opioid antagonist and 24 device. Prior authorization may be required for non-generic forms of 25 opioid antagonists and devices. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [Official text from the New York Legislature. Formatting has been adapted for reading on Ratifi.